This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 28/7/1283    most recent ATVBAHA.108.165753v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhao, L. Articles by Puré, E. Search for Related Content PubMed PubMed Citation Articles by Zhao, L. Articles by Puré, E.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1283.)
© 2008 American Heart Association, Inc.

Integrative Physiology/Experimental Medicine

CD44 Expressed on Both Bone Marrow–Derived and Non–Bone Marrow–Derived Cells Promotes Atherogenesis in ApoE-Deficient Mice

Liang Zhao; Eric Lee; Alicia M. Zukas; Melissa K. Middleton; Michelle Kinder; Pinak S. Acharya; Jason A. Hall; Daniel J. Rader; Ellen Puré

From the The Wistar Institute (L.Z., E.L., A.M.Z., M.K.M., M.K., P.S.A., J.A.H., E.P.), Philadelphia, Pa; the Department of Medicine (P.S.A., D.J.R., E.P.) and the Immunology Graduate Group (M.K.M., M.K., E.P.), University of Pennsylvania School of Medicine, Philadelphia; and the Ludwig Institute for Cancer Research (E.P.), Philadelphia, Pa.

Correspondence to Ellen Puré, PhD, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. E-mail pure{at}wistar.org

Objective— The purpose of this study was to distinguish the contributions of CD44 expressed on bone marrow–derived and non–bone marrow–derived cells to atherosclerosis.

Methods and Results— Using bone marrow chimeras, we compared the contributions of CD44 expressed on bone marrow–derived cells versus non–bone marrow–derived cells to the vascular inflammation underlying atherosclerosis. We show that CD44 in both bone marrow–derived and non–bone marrow–derived compartments promotes atherosclerosis in apoE^–/– mice and mediates macrophage and T cell recruitment to lesions in vivo. We also demonstrate that CD44 on endothelial cells (ECs) as well as on macrophages and T cells enhances leukocyte-endothelial cell adhesion and transendothelial migration in vitro. Furthermore, CD44 on vascular smooth muscle cells (VSMCs) regulates their hyaluronan (HA)-dependent migration. Interestingly, in mice lacking CD44 in both compartments, where we observed the least inflammation, we also observed enhanced fibrous cap formation.

Conclusions— CD44 expressed on bone marrow–derived and non–bone marrow–derived cells both promote atherosclerosis in apoE-deficient mice. Furthermore, CD44 plays a pivotal role in determining the balance between inflammation and fibrosis in atherosclerotic lesions which can impact clinical outcome in humans.

Key Words: CD44 • atherosclerosis • apoE • bone marrow chimera • fibrous cap